These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22361603)

  • 1. Protective effect of telmisartan against endothelial dysfunction after coronary drug-eluting stent implantation in hypertensive patients.
    Terashima M; Kaneda H; Nasu K; Matsuo H; Habara M; Ito T; Tanaka N; Rathore S; Kinoshita Y; Kimura M; Ehara M; Suzuki Y; Suzuki T
    JACC Cardiovasc Interv; 2012 Feb; 5(2):182-90. PubMed ID: 22361603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents.
    Mitsutake Y; Ueno T; Yokoyama S; Sasaki K; Sugi Y; Toyama Y; Koiwaya H; Ohtsuka M; Nakayoshi T; Itaya N; Chibana H; Kakuma T; Imaizumi T
    JACC Cardiovasc Interv; 2012 Sep; 5(9):966-73. PubMed ID: 22995884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month comparison of coronary endothelial dysfunction associated with sirolimus-eluting stent versus Paclitaxel-eluting stent.
    Kim JW; Suh SY; Choi CU; Na JO; Kim EJ; Rha SW; Park CG; Seo HS; Oh DJ
    JACC Cardiovasc Interv; 2008 Feb; 1(1):65-71. PubMed ID: 19393147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of effects of telmisartan and valsartan on late lumen loss and inflammatory markers after sirolimus-eluting stent implantation in hypertensive patients.
    Hong SJ; Shim WJ; Choi JI; Joo HJ; Shin SY; Park SM; Lim SY; Lim DS
    Am J Cardiol; 2007 Dec; 100(11):1625-9. PubMed ID: 18036359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation.
    Kitahara H; Kobayashi Y; Iwata Y; Fujimoto Y; Komuro I
    Am J Cardiol; 2011 Jul; 108(2):214-9. PubMed ID: 21565324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients.
    Hong SJ; Choi SC; Ahn CM; Park JH; Kim JS; Lim DS
    Heart; 2011 Sep; 97(17):1425-32. PubMed ID: 21700754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, randomized, single-blind comparison of effects of 6 months of treatment with telmisartan versus enalapril on high-molecular-weight adiponectin concentrations in patients with coronary artery disease.
    Satoh M; Tabuchi T; Minami Y; Takahashi Y; Itoh T; Nakamura M
    Clin Ther; 2009 Oct; 31(10):2113-25. PubMed ID: 19922882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation.
    Aoki Y; Ishikawa K; Miura K; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    J Cardiol; 2016 Mar; 67(3):236-40. PubMed ID: 26194867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension.
    Marketou ME; Kontaraki JE; Tsakountakis NA; Zacharis EA; Kochiadakis GE; Arfanakis DA; Parthenakis F; Chlouverakis G; Vardas PE
    Am J Cardiol; 2011 Jan; 107(1):59-63. PubMed ID: 21146687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
    Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
    Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of endothelium-dependent and -independent vasomotor response after abluminal biodegradable polymer biolimus-eluting stent and persistent polymer everolimus-eluting stent implantation (COMPARE-IT).
    Puricel S; Kallinikou Z; Espinola J; Arroyo D; Goy JJ; Stauffer JC; Baeriswyl G; Smits PC; Cook S; Togni M
    Int J Cardiol; 2016 Jan; 202():525-31. PubMed ID: 26440470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergism of telmisartan and amlodipine on blood pressure reduction and cardiorenal protection in hypertensive rats.
    Liu W; Wang W; Song SW; Gu XF; Ma XJ; Su FY; Zhang H; Liu AJ; Su DF
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):308-16. PubMed ID: 21266915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan improves endothelial function in patients with essential hypertension.
    Benndorf RA; Appel D; Maas R; Schwedhelm E; Wenzel UO; Böger RH
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):367-71. PubMed ID: 18049303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and vascular protective effects of telmisartan in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Sawada K
    Hypertens Res; 2006 Aug; 29(8):567-72. PubMed ID: 17137211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial.
    Iwata Y; Fujimoto Y; Morino T; Sugimoto K; Ohkubo K; Kadohira T; Fukushima K; Kitahara H; Komuro I; Kobayashi Y
    Am Heart J; 2013 Mar; 165(3):408-14. PubMed ID: 23453111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific coronary drug-eluting stents interfere with distal microvascular function after single stent implantation in pigs.
    van den Heuvel M; Sorop O; Batenburg WW; Bakker CL; de Vries R; Koopmans SJ; van Beusekom HM; Duncker DJ; Danser AH; van der Giessen WJ
    JACC Cardiovasc Interv; 2010 Jul; 3(7):723-30. PubMed ID: 20650434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.
    Hamilos MI; Ostojic M; Beleslin B; Sagic D; Mangovski L; Stojkovic S; Nedeljkovic M; Orlic D; Milosavljevic B; Topic D; Karanovic N; Wijns W;
    J Am Coll Cardiol; 2008 Jun; 51(22):2123-9. PubMed ID: 18510958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.
    Hamilos M; Sarma J; Ostojic M; Cuisset T; Sarno G; Melikian N; Ntalianis A; Muller O; Barbato E; Beleslin B; Sagic D; De Bruyne B; Bartunek J; Wijns W
    Circ Cardiovasc Interv; 2008 Dec; 1(3):193-200. PubMed ID: 20031678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
    Neutel JM; Smith DH; Reilly PA
    Int J Clin Pract; 1999; 53(3):175-8. PubMed ID: 10665127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.